Accepting Living Kidney Donors with Preexisting Diabetes Mellitus: A Perspective on the Recent OPTN Policy Change-July 2022.
作者信息
Soliman Karim M, Daoud Ahmed, Posadas Salas Maria Aurora, Rice Teresa, Uehara Genta, Shayto Rani, Fülöp Tibor, DuBay Derek, Casey Michael J
机构信息
Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Division of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina.
出版信息
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):127-129. doi: 10.2215/CJN.09460822. Epub 2022 Nov 8.
Abstract
摘要
相似文献
1
Accepting Living Kidney Donors with Preexisting Diabetes Mellitus: A Perspective on the Recent OPTN Policy Change-July 2022.接受患有糖尿病前期的活体肾捐赠者：对器官获取与移植网络（OPTN）2022年7月政策变更的看法
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):127-129. doi: 10.2215/CJN.09460822. Epub 2022 Nov 8.
2
Using Linked Health Service Data in Multimodal Modeling of Kidney Transplant Waitlist Outcomes: Protocol for the Maximizing Organ Donor Utility Systemwide (MODUS) Study.在肾移植等待名单结果的多模态建模中使用关联健康服务数据：全系统最大化器官捐赠者效用系统（MODUS）研究方案。
JMIR Res Protoc. 2025 Jul 29;14:e67588. doi: 10.2196/67588.
3
The direct and indirect economic costs incurred by living kidney donors-a systematic review.活体肾供者产生的直接和间接经济成本——一项系统综述
Nephrol Dial Transplant. 2006 Jul;21(7):1952-60. doi: 10.1093/ndt/gfl069. Epub 2006 Mar 22.
4
The real unmet need: A multifactorial approach for identifying sensitized kidney candidates with low access to transplant.真正未满足的需求：一种多因素方法，用于确定低移植机会的致敏肾脏候选者。
Clin Transplant. 2023 May;37(5):e14946. doi: 10.1111/ctr.14946. Epub 2023 Mar 13.
5
Effectiveness of a Mobile Health System on Compliance With 2-Year Living Kidney Donor Follow-Up in the United States.美国移动健康系统对活体肾供体两年随访依从性的影响。
Clin Transplant. 2025 Apr;39(4):e70139. doi: 10.1111/ctr.70139.
6
New OPTN requirements and resources for the living donor kidney transplant programs.
Prog Transplant. 2013 Jun;23(2):117. doi: 10.7182/prtr.23.2.a8px2754863u0461.
7
Kidney accelerated placement project: Outcomes and lessons learned.肾脏加速安置项目：成果与经验教训。
Am J Transplant. 2022 Jan;22(1):210-221. doi: 10.1111/ajt.16859. Epub 2021 Oct 25.
8
The Life-Saving Benefit of the Living Donor Kidney Evaluation: A Mini Review.
Clin Transplant. 2025 Aug;39(8):e70253. doi: 10.1111/ctr.70253.
9
Written informed consent for living kidney donors: practices and compliance with CMS and OPTN requirements.活体肾捐献者的书面知情同意：实践与 CMS 和 OPTN 要求的符合情况。
Am J Transplant. 2013 Oct;13(10):2713-21. doi: 10.1111/ajt.12406. Epub 2013 Sep 10.
10
A systematic review of kidney transplantation from expanded criteria donors.对扩大标准供体肾移植的系统评价。
Am J Kidney Dis. 2008 Sep;52(3):553-86. doi: 10.1053/j.ajkd.2008.06.005.
引用本文的文献
1
ISOT position statement on the feasibility of an organ for transplantation from brain-dead deceased donors: a Delphi consensus.国际器官移植学会（ISOT）关于脑死亡死者供体器官移植可行性的立场声明：德尔菲共识
Lancet Reg Health Southeast Asia. 2025 Jul 16;39:100628. doi: 10.1016/j.lansea.2025.100628. eCollection 2025 Aug.
2
Dissecting the Delicate Dynamics of Donation in Dysglycemia.剖析血糖异常情况下捐赠的微妙动态。
Indian J Nephrol. 2025 May-Jun;35(3):319-321. doi: 10.25259/IJN_623_2024. Epub 2025 Jan 31.
3
Artificial intelligence assisted risk prediction in organ transplantation: a UK Live-Donor Kidney Transplant Outcome Prediction tool.人工智能辅助的器官移植风险预测：一种英国活体供肾移植结果预测工具。
Ren Fail. 2025 Dec;47(1):2431147. doi: 10.1080/0886022X.2024.2431147. Epub 2025 Jan 21.
4
Comparison between female kidney donors with prediabetes and without diabetes in blood pressure measurements, kidney and diabetes biomarkers: a prospective cohort study.有糖尿病前期的女性肾脏供体与无糖尿病的女性肾脏供体在血压测量、肾脏和糖尿病生物标志物方面的比较：一项前瞻性队列研究。
J Nephrol. 2024 Dec 15. doi: 10.1007/s40620-024-02168-3.
本文引用的文献
1
Abridged for Primary Care Providers.为初级保健提供者节略。
Clin Diabetes. 2022 Jan;40(1):10-38. doi: 10.2337/cd22-as01.
2
Hypertension and obesity in living kidney donors.活体肾供体中的高血压与肥胖
World J Transplant. 2021 Jun 18;11(6):180-186. doi: 10.5500/wjt.v11.i6.180.
3
Outcomes of Kidney Donors With Impaired Fasting Glucose.空腹血糖受损供者的结局。
Transplantation. 2022 Jan 1;106(1):138-146. doi: 10.1097/TP.0000000000003665.
4
Plasma triglyceride levels and central obesity predict the development of kidney injury in Chinese community older adults.血浆甘油三酯水平和中心性肥胖可预测中国社区老年人群肾脏损伤的发生。
Ren Fail. 2019 Nov;41(1):946-953. doi: 10.1080/0886022X.2019.1655451.
5
Risk of ESKD in Older Live Kidney Donors with Hypertension.患有高血压的老年活体肾供者发生终末期肾病的风险
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.
6
British Transplantation Society / Renal Association UK Guidelines for Living Donor Kidney Transplantation 2018: Summary of Updated Guidance.英国移植学会/英国肾脏协会2018年活体肾移植指南：更新指南摘要
Transplantation. 2018 Jul;102(7):e307. doi: 10.1097/TP.0000000000002253.
7
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.KDIGO 活体肾捐献者评估与管理临床实践指南
Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109. doi: 10.1097/TP.0000000000001769.
8
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.欧洲肾脏最佳实践指南：肾脏供体与受体评估及围手术期护理
Nephrol Dial Transplant. 2015 Nov;30(11):1790-7. doi: 10.1093/ndt/gfu216. Epub 2014 Jul 9.
9
Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis.2 型糖尿病合并肾病患者中糖尿病视网膜病变预测糖尿病肾病的Meta 分析。
Diabetologia. 2013 Mar;56(3):457-66. doi: 10.1007/s00125-012-2796-6. Epub 2012 Dec 12.
10
Body mass index and risk for end-stage renal disease.体重指数与终末期肾病风险
Ann Intern Med. 2006 Jan 3;144(1):21-8. doi: 10.7326/0003-4819-144-1-200601030-00006.
Zotero 插件